Key facts
- It has raised $90K; the latest was Seed Round ($90K) in Oct 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Eye Guardian
- ·The full record, as it builds
Funding rounds
No funding rounds for Eye Guardian are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eye Guardian
Developer of a glaucoma management technology designed to monitor intraocular pressure in real time. The company produces smart glasses that capture eye surface speckle patterns and analyze them using artificial intelligence to provide alerts related to eye health, enabling healthcare professionals to improve eyesight of patients with ocular hypertension by providing timely treatments.
- Sector
- Healthcare
- HQ
- Bermuda Dunes, CA, United States
- Founded
- 2025
- Website
- eyeguardian.ai/
- Ownership
- Privately Held (backing)
Eye Guardian doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eye Guardian shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eye Guardian in its N-PORT filings yet. We sweep new filings monthly.